Lupin gets 13 observations from USFDA for its New Jersey plant - Economic Times

US FDA inspection of the Company's Somerset, New Jersey (US) facility. The USFDA has concluded an inspection at the Company's wholly owned subsidiary Novel Laboratories, Inc., based in Somerset, NJ. The inspection commenced on March 7, 2022 and concluded on M…

Drug maker Lupin on Thursday said its New Jersey facility has received 13 observations from the US drug regulator. The facility accounts for less than 5 percent Lupin's global turnover. The observa… [+935 chars]

full article...